^
Association details:
Biomarker:No biomarker
Cancer:B Acute Lymphoblastic Leukemia
Drug:clofarabine (DNA synthesis inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
REGIMENS FOR RELAPSED OR REFRACTORY Ph-NEGATIVE B-ALL…Other Recommended Regimens...Clofarabine alone or in combination (eg, clofarabine, cyclophosphamide, etoposide)